Decheng Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Decheng Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,317,924	Closed	-$330M	–	28
2024 Q1	$330M	Buy	8,317,924 +1,234,636	+17%	+$36.4M	44.22%	1
2023 Q4	$135M	Buy	+7,083,288	New	+$98.4M	37.72%	1

Decheng Capital's ALPN Position: Q2 2024 in Review

Decheng Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 8,317,924 shares — an estimated $330M sold.

Decheng Capital first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $330M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Decheng Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Decheng Capital sold 8,317,924 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $330M.
Decheng Capital first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
Decheng Capital's Alpine Immune Sciences Inc position peaked at $330M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Decheng Capital's 13F filing for Q2 2024, filed 14 Aug 2024.